Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunologic Factors”

223 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 223 results

Large-scale testing (Phase 3)UnknownNCT00006397
What this trial is testing

Differences Between Women and Men Taking a Combination of Indinavir, Ritonavir, Enteric-Coated Didanosine, and Stavudine Who Previously Took Anti-HIV Drugs

Who this might be right for
HIV Infections
PPD Development, LP 200
Testing effectiveness (Phase 2)WithdrawnNCT05218408
What this trial is testing

CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type

Who this might be right for
Astrocytoma, Grade IVGlioblastomaGiant Cell Glioblastoma+1 more
Celularity Incorporated
Testing effectiveness (Phase 2)Active Not RecruitingNCT06001385
What this trial is testing

HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Leukemia+8 more
Center for International Blood and Marrow Transplant Research 313
Not applicableStudy completedNCT01946217
What this trial is testing

Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials

Who this might be right for
HIV InfectionMalignant NeoplasmPrecancerous Condition
AIDS Malignancy Consortium 82
Testing effectiveness (Phase 2)Study completedNCT05156723
What this trial is testing

Study of the Immunogenicity, Safety and Tolerability of the Convacell Vaccine.

Who this might be right for
COVID-19Immunologic FactorsCoronavirus Infections+1 more
St. Petersburg Research Institute of Vaccines and Sera 155
Not applicableStudy completedNCT02092558
What this trial is testing

Evaluation of Immunological Disorders of T Lymphocytes and Endocrinological Disorders as Pathogen Factors in Patients With Metaplasia of Urinary Bladder

Who this might be right for
The Follow-up Duration Was 1-8 Years.The Main Reasons Behind Visiting the Hospital Were Recurrent Urinary Tract Infection,Urinary Urgencies, Pollakiuria, Difficulty in Initiating Micturition, Pain in Hypogastrium,+2 more
Children's Hospital, Dziekanów Leśny, Poland
Not applicableStudy completedNCT00159068
What this trial is testing

Analysis of Genetic Factors Which May Influence the Course of HIV Infection

Who this might be right for
HIV Infection
Deborah Rund 100
Not applicableUnknownNCT00155805
What this trial is testing

Immunologic Factors in Reflux Esophagitis and Barrett's Esophagus

Who this might be right for
Reflux EsophagitisHiatal Hernia
National Taiwan University Hospital 90
Large-scale testing (Phase 3)UnknownNCT01204801
What this trial is testing

Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer Tumors

Who this might be right for
Breast Cancer
Medifocus, Inc. 238
Not applicableStudy completedNCT01519141
What this trial is testing

Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection

Who this might be right for
Atherosclerosis
University of California, San Francisco 579
Not applicableLooking for participantsNCT05026723
What this trial is testing

Food as Medicine for HIV and Diabetes

Who this might be right for
Diabetes Mellitus, Type 2HIV InfectionsPreDiabetes
University of North Carolina, Chapel Hill 200
Not applicableStudy completedNCT00001120
What this trial is testing

Patients With AIDS Syndrome

Who this might be right for
Sarcoma, KaposiLymphoma, Non-HodgkinHIV Infections+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 5,000
Not applicableStudy completedNCT00073424
What this trial is testing

Factors Affecting Adherence to Anti-HIV Drug Regimens in Children and Adolescents

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 200
Testing effectiveness (Phase 2)Looking for participantsNCT05826535
What this trial is testing

Study of LYL314 in Aggressive Large B-Cell Lymphoma

Who this might be right for
Relapsed Non-Hodgkin LymphomaRefractory Non-Hodgkin LymphomaNon-Hodgkin Lymphoma+1 more
Lyell Immunopharma, Inc. 270
Post-approval studies (Phase 4)Study completedNCT00296153
What this trial is testing

Omacor and Cardiovascular Risk Factors in HIV Patients on HAART Treatment

Who this might be right for
Human Immunodeficiency VirusIschemic Heart Disease
Pronova BioPharma 51
Not applicableStudy completedNCT03777371
What this trial is testing

Anti-HIV False Positivity Rate in Pregnant Women; and Investigating the Factors Affecting This Situation

Who this might be right for
HIV SeropositivityAcquired Immunodeficiency SyndromePregnancy, High Risk
Kanuni Sultan Suleyman Training and Research Hospital 128
Testing effectiveness (Phase 2)Study completedNCT03942406
What this trial is testing

Study of BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator(TM)), Prime + Boost, in Healthy Adults

Who this might be right for
PertussisWhooping Cough
ILiAD Biotechnologies 300
Testing effectiveness (Phase 2)Study completedNCT03198689
What this trial is testing

Brentuximab Vedotin in Early Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 11
Testing effectiveness (Phase 2)Study completedNCT04034290
What this trial is testing

Randomized Placebo-controlled Study Study of the Safety, Reactogenicity and Immunogenicity of the GamFluVac

Who this might be right for
Healthy Volunteers
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 224
Testing effectiveness (Phase 2)Study completedNCT00074425
What this trial is testing

BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 3,101
Load More Results
2